Category: Biopharmaceuticals
Global Biopharmaceuticals
-
Drug Discovery Market by Drug Type (Biologic Drugs, Small Molecule Drugs), Technology (Bioanalytical Instruments, Biochips, Bioinformatics), Therapeutic Area, End User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 71.12 billion in 2024, at a CAGR 14.10% to reach USD 157.13 billion by 2030. Drug discovery is a multifaceted and intricate process that encompasses the identification of ... Read More
-
Laboratory Proficiency Testing Market by Technology (Cell Culture, Chromatography, Immunoassays), Application (Biologics, Cannabis/Opioids, Clinical Diagnostics), End-Use - Global Forecast 2024-2030
... expected to reach USD 2.39 billion in 2024, at a CAGR 7.85% to reach USD 3.77 billion by 2030. Laboratory Proficiency Testing (LPT) is a method used to evaluate and monitor the performance of laboratories ... Read More
-
Biologics Market by Source (Mammalian, Microbial), Product (Antisense & RNAi Therapeutics, Monoclonal Antibodies, Recombinant Hormones or Proteins), Indication, End-user - Global Forecast 2024-2030
... and expected to reach USD 430.59 billion in 2024, at a CAGR 6.39% to reach USD 626.34 billion by 2030. Biologics are integral to the biomedical sector, focusing on developing, manufacturing, and distributing biological treatments ... Read More
-
Healthcare Distribution Market - By Type (Pharmaceutical [OTC, Generic, Branded Drugs], Biopharmaceutical [Vaccines, Monoclonal Antibodies], & Medical Device Distribution Services), End-use (Hospital, Retail Pharmacies) – Global Forecast (2024 – 2032)
... demonstrate a 7.1% CAGR between 2024 and 2032, propelled by innovations in warehouse management systems (WMS) and a heightened focus on patient safety. Advanced WMS technologies improve efficiency, accuracy, and regulatory compliance, ensuring the secure ... Read More
-
Biopharmaceutical CMO and CRO Market Share, Global Industry Growth, Analysis, Size and Forecast 2024-2032
... 2024 to 2032. The biopharmaceutical industry has witnessed tremendous growth in recent years, fueled by advancements in biotechnology, the increasing prevalence of chronic diseases, and a heightened focus on personalized medicine. Central to this growth ... Read More
-
Global Monoclonal antibodies (mAbs) Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... USD 4812.9 million in 2023 and is forecast to a readjusted size of USD 5470.7 million by 2030 with a CAGR of 1.8% during review period. A biosimilar medicine is a medicinal product of biological ... Read More
-
Blockchain in Healthcare Market Share, Size, Trends, Industry Analysis Report, By End-Use (Healthcare Payers, Biopharmaceutical & Medical Device Companies, Healthcare Providers); By Network Type; By Application; By Region; Segment Forecast, 2024 - 2032
... blockchain in healthcare market size is expected to reach USD 105698.76 million by 2032, according to a new study by Polaris Market Research. The report “Blockchain in Healthcare Market Share, Size, Trends, Industry Analysis Report, ... Read More
-
Biosimilars and Follow-On Biologics Market Report 2024-2034
... industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increasing Demand of Drugs For Treating ... Read More
-
Global Interchangeable Biosimilars Market Growth 2024-2030
... have minor differences in composition, quality, purity and biological activity compared to the reference biological drug, but these differences do not affect their efficacy or safety. Interchangeable biosimilars are generally considered to be effective alternatives ... Read More
-
Biopharmaceutical Process Analytical Technology Market Size by Technology (LC, GC, MS, qPCR, NGS, NMR, Raman, IR Spectroscopy), Product (Analyzer, Sensor, Software), Application (Vaccine, Biologics, CGT), and End User - Global Forecast to 2029
... biopharmaceutical process analytical technology market is projected to reach USD 2.6 billion by 2029 from USD 1.2 billion in 2024, at a CAGR of 16.0% during the forecast period of 2024 to 2029. The market ... Read More
-
Biopharmaceutical Contract Manufacturing Organization (CMO) Global Market Opportunities And Strategies To 2033
... And PackagingCovering: Catalent Inc.; Cytiva; Rentschler Biopharma; Boehringer Ingelheim GmbH; AGC Biologics Inc. Biopharmaceutical Contract Manufacturing Organization (CMO) Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and ... Read More
-
Biologics Safety Testing Market by Product & Service (Consumables, Instrument, Services), Test Type (Mycoplasma, Sterility, Endotoxin, Bioburden, Virus Safety), Application (Vaccines, mAbs, Cell & Gene Therapy, Blood Products) - Global Forecast to 2029
... safety testing market is projected to reach USD 7.2 billion by 2029 from an estimated USD 4.2 billion in 2024, at a CAGR of 11.1% from 2024 to 2029. The growth of this market can ... Read More
-
Microcarrier Market Analysis and Forecast to 2033: By Material Type (Collagen-based, Gelatin-based, Hyaluronic Acid-based, Polystyrene-based, Dextran-based, Modified Polyvinyl Alcohol), Technology (Two-Dimensional, Three-Dimensional), Application (Regenerative Medicine, Cultured Meat Production, Vaccine Production, Cell Therapy, Biologics Manufacturing, Stem Cell Research, Tissue Engineering), Equipment (Bioreactors, Cell Culture Vessels, Centrifuges, Incubators, Cell Counters, Separation Systems, Storage Systems, Processing Systems), Size of Microcarriers [Small (<1,000 µm), Medium (1,000–2,000 µm), Large (>2,000 µm)], End-User (Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institutes), and Region
... Cell Research, Tissue Engineering), Equipment (Bioreactors, Cell Culture Vessels, Centrifuges, Incubators, Cell Counters, Separation Systems, Storage Systems, Processing Systems), Size of Microcarriers [Small ( 2,000 µm)], End-User (Biopharmaceutical Companies, Contract Research Organizations, Academic and Research ... Read More
-
Global Pharmaceutical Continuous Manufacturing
... adoption in specific areas such as small molecule oral solid dosage forms and large molecules, the market has consistently demonstrated robust year-on-year growth. Projections indicate that the global pharmaceutical continuous manufacturing market will experience a ... Read More
-
2024 Global Forecast for Biosimilar Contract Manufacturing Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
2024 Global Forecast for Biologics Contract Development Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD ... Read More
-
2024 Global Forecast for Biosimilar Monoclonal Antibodies Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
Global Erythropoietin Drugs Databank Market Report
... 2029. Cancer segment is expected to be the highest contributor to this market, with $3,381.2 Million in 2020, and is anticipated to reach $6,689.5 Million by 2029, registering a CAGR of 7.92%. Renal Diseases segment ... Read More
-
Global Membrane Bioreactor Systems Databank Market Report
... 2021 to 2029. Flat Sheet segment is expected to be the highest contributor to this market, with $4,081.1 Million in 2020, and is anticipated to reach $7,726.6 Million by 2029, registering a CAGR of 7.40%. ... Read More
-
Global Biologics and Biosimilars Market Size, Manufacturers, Opportunities and Forecast to 2030
... biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. ... Read More
-
Global Biologics and Biosimilars Market Analysis and Forecast 2024-2030
... proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. A biosimilar in ... Read More
-
Global Bioreactors Databank Market Report
... from 2023 to 2031. Single-use segment is expected to be the highest contributor to this market, with $12,231.2 Million in 2022, and is anticipated to reach $20,945.6 Million by 2031, registering a CAGR of 6.20%. Read More
-
Global Biologics and Biosimilars Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but ... Read More
-
Global Biologics and Biosimilars Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a ... Read More
-
Global Wound Care Biologics Databank Market Report
... 2023 to 2031. Ulcers segment is expected to be the highest contributor to this market, with $730.2 Million in 2022, and is anticipated to reach $1,212.3 Million by 2031, registering a CAGR of 5.84%. Surgical ... Read More
Research Assistance
